Quantum-Si incorporated logo

QSIAWQuantum-Si incorporated

NASDAQ · Healthcare · Medical Devices

Quantum-Si incorporated (QSIAW) is a medical devices company listed on NASDAQ. It is led by Jeffrey Alan Hawkins, based in 29 Business Park Drive, Branford, CT, United States, 06405, with about 149 employees. Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.

Latest reported QSIAW revenue for 2025-09-30 was $552.0K. Net income was -$35.7M. Revenue was down 6.6% from 2025-06-30 to 2025-09-30. QSIAW currently screens at market cap $1.44B.

Use this QSIAW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the QSIAW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the QSIAW SEC filings page. Lician reads the product cache first so this HTML stays unique to Quantum-Si incorporated even when a live quote feed is slow.

About Quantum-Si incorporated

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.

QSIAW Key Statistics

Market Cap

$1.44B

00

EPS

-$0.71

Revenue

$3.06M

Net Income

-$101.01M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

+182.6%

Profit Margin

-3303.0%

Employees

149

QSIAW Financials

Annual income statement in USD. Latest reported periods first.

QSIAW annual income statement across FY2024, FY2023, FY2022, FY2021
LineFY2024FY2023FY2022FY2021
Revenue$3.06M$1.08M$0.00$0.00
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00$0.00
Net Income-$101.01M-$95.96M-$132.44M-$94.99M
EPS (Diluted)-$0.71-$0.68-$0.95-$1.19

Total Assets

$247.87M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$49.24M

Operating Cash Flow

-$87.80M

Free Cash Flow

$0.00

Quantum-Si incorporated Company Information

President, CEO & Director
Jeffrey Alan Hawkins
Headquarters
29 Business Park Drive, Branford, CT, United States, 06405
Phone
866 688 7374
IPO / Founded
2021-06-11
Industry
Medical Devices
Data Updated:

Upcoming Events for QSIAW